Annual report pursuant to Section 13 and 15(d)

Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.24.1
Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Non-capital losses carried forward $ 26,044 $ 21,000
Research and development expenditures 817 817
Share issue costs 495 338
Patents and other 358 320
Accruals 214 213
Share-based compensation 212 166
Property and equipment (102) (117)
Total deferred tax asset, net 28,038 22,737
Valuation allowance (28,038) (22,737)
Net deferred tax asset $ 0 $ 0